share_log

SILENCE THERAPEUTICS PLC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.

SILENCE THERAPEUTICS PLC | SC 13G:超過5%持股股東披露文件-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%)等

2022/08/22 16:13
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息